ZA200409777B - Orthopaedic materials derived from keratin - Google Patents
Orthopaedic materials derived from keratin Download PDFInfo
- Publication number
- ZA200409777B ZA200409777B ZA200409777A ZA200409777A ZA200409777B ZA 200409777 B ZA200409777 B ZA 200409777B ZA 200409777 A ZA200409777 A ZA 200409777A ZA 200409777 A ZA200409777 A ZA 200409777A ZA 200409777 B ZA200409777 B ZA 200409777B
- Authority
- ZA
- South Africa
- Prior art keywords
- keratin
- bone
- biocompatible
- sulfonated
- compression
- Prior art date
Links
- 102000011782 Keratins Human genes 0.000 title claims description 187
- 108010076876 Keratins Proteins 0.000 title claims description 187
- 239000000463 material Substances 0.000 title claims description 137
- 210000000988 bone and bone Anatomy 0.000 claims description 71
- 238000000034 method Methods 0.000 claims description 43
- 239000000126 substance Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 28
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 28
- 102000004169 proteins and genes Human genes 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 27
- 238000011282 treatment Methods 0.000 claims description 25
- 238000005406 washing Methods 0.000 claims description 20
- 102000012411 Intermediate Filament Proteins Human genes 0.000 claims description 16
- 108010061998 Intermediate Filament Proteins Proteins 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 238000007906 compression Methods 0.000 claims description 16
- 230000006835 compression Effects 0.000 claims description 16
- 239000011148 porous material Substances 0.000 claims description 16
- 239000003361 porogen Substances 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000560 biocompatible material Substances 0.000 claims description 9
- 230000003416 augmentation Effects 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 206010017076 Fracture Diseases 0.000 claims description 5
- 238000011161 development Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000005728 strengthening Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 4
- 159000000007 calcium salts Chemical class 0.000 claims description 3
- 230000008595 infiltration Effects 0.000 claims description 2
- 238000001764 infiltration Methods 0.000 claims description 2
- 210000004663 osteoprogenitor cell Anatomy 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 34
- 235000018102 proteins Nutrition 0.000 description 26
- 239000010408 film Substances 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 20
- 239000000047 product Substances 0.000 description 14
- GEHJBWKLJVFKPS-UHFFFAOYSA-N bromochloroacetic acid Chemical compound OC(=O)C(Cl)Br GEHJBWKLJVFKPS-UHFFFAOYSA-N 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 11
- 230000012010 growth Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- ZZTCCAPMZLDHFM-UHFFFAOYSA-N ammonium thioglycolate Chemical compound [NH4+].[O-]C(=O)CS ZZTCCAPMZLDHFM-UHFFFAOYSA-N 0.000 description 9
- 210000002950 fibroblast Anatomy 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 210000002268 wool Anatomy 0.000 description 9
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 8
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 7
- 241001494479 Pecora Species 0.000 description 7
- 229960003067 cystine Drugs 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 210000000963 osteoblast Anatomy 0.000 description 7
- 210000002997 osteoclast Anatomy 0.000 description 7
- 239000008188 pellet Substances 0.000 description 7
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 239000012620 biological material Substances 0.000 description 6
- 239000003638 chemical reducing agent Substances 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 210000003963 intermediate filament Anatomy 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 5
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000012829 orthopaedic surgery Methods 0.000 description 4
- 230000011164 ossification Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 210000003284 horn Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010029113 Neovascularisation Diseases 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010061363 Skeletal injury Diseases 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000006065 biodegradation reaction Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 239000008366 buffered solution Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 150000002019 disulfides Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000000003 hoof Anatomy 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 239000011872 intimate mixture Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000004264 monolayer culture Methods 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000009702 powder compression Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000002407 reforming Methods 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 101710200191 Feather keratin Proteins 0.000 description 1
- 208000007356 Fracture Dislocation Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000283986 Lepus Species 0.000 description 1
- 101100328463 Mus musculus Cmya5 gene Proteins 0.000 description 1
- 206010031264 Osteonecrosis Diseases 0.000 description 1
- NOKPBJYHPHHWAN-REOHCLBHSA-N S-sulfo-L-cysteine Chemical compound OC(=O)[C@@H](N)CSS(O)(=O)=O NOKPBJYHPHHWAN-REOHCLBHSA-N 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000030944 contact inhibition Effects 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000006334 disulfide bridging Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000035194 endochondral ossification Effects 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000005088 multinucleated cell Anatomy 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 230000001599 osteoclastic effect Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000003168 reconstitution method Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000000807 solvent casting Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Composite Materials (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ51945602 | 2002-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200409777B true ZA200409777B (en) | 2006-08-30 |
Family
ID=29728989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200409777A ZA200409777B (en) | 2002-06-10 | 2004-12-02 | Orthopaedic materials derived from keratin |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7297342B2 (enExample) |
| EP (1) | EP1534353A4 (enExample) |
| JP (1) | JP4551761B2 (enExample) |
| CN (1) | CN100506294C (enExample) |
| AU (1) | AU2003238745B2 (enExample) |
| BR (1) | BR0311723A (enExample) |
| CA (1) | CA2488721A1 (enExample) |
| MX (1) | MXPA04012434A (enExample) |
| NZ (1) | NZ550755A (enExample) |
| WO (1) | WO2003103737A1 (enExample) |
| ZA (1) | ZA200409777B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA011388B1 (ru) * | 2003-12-19 | 2009-02-27 | Кератек Лимитед | Продукты для ухода за ранами, содержащие кератин |
| US7579317B2 (en) | 2005-03-11 | 2009-08-25 | Keratec, Ltd. | Nutraceutical composition comprising soluble keratin or derivative thereof |
| US8920827B2 (en) * | 2005-10-21 | 2014-12-30 | Wake Forest University Health Sciences | Keratin bioceramic compositions |
| US20070207097A1 (en) * | 2006-02-21 | 2007-09-06 | Kelly Robert J | Treating hair or nails with internal wool lipids |
| WO2008040357A1 (en) * | 2006-10-02 | 2008-04-10 | Coloplast A/S | Cross-linking of foams of s-sulfonated keratin |
| WO2008070091A1 (en) * | 2006-12-06 | 2008-06-12 | Keratec, Ltd. | Bone void fillers and methods of making the same |
| WO2008073376A2 (en) * | 2006-12-11 | 2008-06-19 | Keratec, Ltd. | Porous keratin construct and method of making the same |
| DE102008053114B4 (de) * | 2008-10-26 | 2011-05-05 | Technische Universität Braunschweig | Pharmazeutischer Keratinschwamm |
| US9045600B2 (en) | 2009-05-13 | 2015-06-02 | Keraplast Technologies, Ltd. | Biopolymer materials |
| AU2011329839B2 (en) | 2010-11-17 | 2016-12-08 | Wake Forest University Health Sciences | Keratin compositions for treatment of bone deficiency or injury |
| AU2012296477B2 (en) | 2011-08-17 | 2017-04-27 | Keratin Biosciences, Inc. | Methods for extracting keratin proteins |
| WO2013025941A1 (en) | 2011-08-17 | 2013-02-21 | Keranetics Llc | Low protein percentage gelling compositions |
| WO2014019672A1 (en) * | 2012-07-31 | 2014-02-06 | Geistlich Pharma Ag | Hydrophilic phosphate group containing dehydrated partially purified bone replacement material |
| CN102836461A (zh) * | 2012-09-25 | 2012-12-26 | 天津工业大学 | 一种力学性能可调控的自体角蛋白矫形材料及其制备方法 |
| CN102827481B (zh) * | 2012-09-25 | 2014-12-24 | 天津工业大学 | 一种角蛋白高弹柔性生物膜及其制备方法 |
| US9827245B2 (en) | 2013-03-15 | 2017-11-28 | KeraNetics, LLC | Keratin compositions comprising halofuginone |
| CN104818414B (zh) * | 2015-03-19 | 2017-08-11 | 中国科学院金属研究所 | 一种具有多孔结构的金属植骨材料及其制备和应用 |
| CN104941005B (zh) * | 2015-05-18 | 2018-02-02 | 天津工业大学 | 一种羟基磷灰石增强角蛋白复合骨材的制备方法 |
| CA3040158A1 (en) | 2016-10-18 | 2018-04-26 | Marquette University | Composite materials containing structural polymers and photoreactive nitric oxide releasing agents and uses thereof for wound dressings |
| CN109481726A (zh) * | 2018-11-26 | 2019-03-19 | 广州新诚生物科技有限公司 | 一种可生物降解的止血骨蜡及其制备方法 |
| US12239948B2 (en) | 2019-06-17 | 2025-03-04 | Marquette University | Materials based on natural pollen grains and uses thereof |
| JP2024100358A (ja) * | 2023-01-16 | 2024-07-26 | 山内 清 | 水不溶性ｓ－スルホン化ケラチンタンパク質を基材とする耐水性成形物の製造方法 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2591945A (en) | 1948-11-12 | 1952-04-08 | Botany Mills Inc | Process for the recovery of protein from wool and other keratinous materials |
| US3567363A (en) | 1965-09-20 | 1971-03-02 | Gillette Co | Modification of keratin to the s-sulfo form |
| NO125657B (enExample) | 1965-09-20 | 1972-10-16 | Gillette Co | |
| US3644084A (en) * | 1968-11-25 | 1972-02-22 | Gillette Co | Treatment of keratin fibers |
| US3619116A (en) | 1969-04-02 | 1971-11-09 | Thomas Burnley & Sons Ltd | Method for scouring wool |
| US3883647A (en) | 1972-12-06 | 1975-05-13 | Ives Lab | Tablet formulation |
| JPS537760A (en) | 1976-07-12 | 1978-01-24 | Agency Of Ind Science & Technol | Modified keratin membrane |
| US4172073A (en) | 1976-11-09 | 1979-10-23 | Chemetron Corporation | Method for the preparation of water-soluble keratinaceous protein using saturated steam and water |
| JPS53119900A (en) | 1977-03-23 | 1978-10-19 | Agency Of Ind Science & Technol | Preparation of aqueous solution of high viscosity and high molecular weight keratin |
| JPS609531B2 (ja) | 1978-04-17 | 1985-03-11 | 積水化学工業株式会社 | 多孔質膜状物の製造方法 |
| JPS57144213A (en) | 1981-03-03 | 1982-09-06 | Kao Corp | Hair treatment |
| FR2521571B1 (fr) | 1982-02-17 | 1986-07-18 | Oreal | Polymere keratinique a residus s-sulfocysteine, son procede de preparation et composition de traitement correspondante |
| US4407793A (en) | 1982-05-26 | 1983-10-04 | Akimova Alla Y | Composition for temporary substitution of bone tissue defects |
| DE3588043T2 (de) | 1984-01-06 | 1996-03-21 | Univ California | Cytokeratin-tumormarkierer und test zu deren nachweis. |
| US4904602A (en) | 1985-11-27 | 1990-02-27 | Repligen Corporation | Thioredoxin shufflease and use thereof |
| JPS63229058A (ja) | 1987-03-17 | 1988-09-22 | 大鳥 泰雅 | 骨形成材料の製法 |
| JPH0737480B2 (ja) | 1987-06-01 | 1995-04-26 | 花王株式会社 | 水溶性ケラチンの製造方法 |
| US5154916A (en) | 1988-04-07 | 1992-10-13 | L'oreal | Eyelash make-up composition based on wax and keratin hydrolysate |
| US4973475A (en) | 1988-10-07 | 1990-11-27 | Revlon, Inc. | Hair treatment and conditioning agents |
| US4969880A (en) | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
| JP2777196B2 (ja) | 1989-06-06 | 1998-07-16 | 株式会社成和化成 | ケラチン加水分解物の製造方法 |
| JP2907938B2 (ja) | 1990-04-13 | 1999-06-21 | 株式会社成和化成 | 化粧品基剤 |
| US5292362A (en) | 1990-07-27 | 1994-03-08 | The Trustees Of Columbia University In The City Of New York | Tissue bonding and sealing composition and method of using the same |
| JPH05222100A (ja) | 1992-02-14 | 1993-08-31 | San Orient Kagaku Kk | 還元型ケラチンペプタイドの製造方法 |
| FR2687577B1 (fr) * | 1992-02-26 | 1995-06-30 | Icp Sa | Biomateriau pour la realisation de produits applicables en medecine humaine particulierement en orthopedie et son procede de fabrication. |
| JPH05320358A (ja) | 1992-05-22 | 1993-12-03 | Ajinomoto Takara Corp:Kk | ケラチン蛋白質高圧成型品 |
| JP3283302B2 (ja) | 1992-09-22 | 2002-05-20 | 株式会社成和化成 | 還元ケラチンの製造方法 |
| US5358935A (en) * | 1992-11-19 | 1994-10-25 | Robert Allen Smith | Nonantigenic keratinous protein material |
| JP2527120B2 (ja) | 1992-12-24 | 1996-08-21 | 共栄社化学株式会社 | 硬ケラチン物質粉末の製造方法 |
| JPH06220713A (ja) | 1993-01-28 | 1994-08-09 | Toray Ind Inc | ポリビニルアルコール系繊維の製造方法 |
| EP0628573A1 (en) | 1993-05-24 | 1994-12-14 | Kao Corporation | Process for producing solubilized protein |
| US5316942A (en) | 1993-06-16 | 1994-05-31 | Battelle Memorial Institute | Process for the production of low-cost soluble high-molecular weight collagen |
| US5602094A (en) | 1994-03-29 | 1997-02-11 | Goddard; David | Treatment of tumors |
| FR2725130B1 (fr) | 1994-09-29 | 1996-10-31 | Oreal | Compositions cosmetiques contenant un compose lipidique de type ceramide et un peptide a une chaine grasse, et leurs utilisations |
| GB9721585D0 (en) * | 1997-10-10 | 1997-12-10 | Geistlich Soehne Ag | Chemical product |
| US6013250A (en) | 1995-06-28 | 2000-01-11 | L'oreal S. A. | Composition for treating hair against chemical and photo damage |
| FR2740036B1 (fr) | 1995-10-20 | 1997-11-28 | Oreal | Nouvelle composition oxydante et nouveau procede pour la deformation permanente ou la decoloration des cheveux |
| CA2239775C (en) * | 1995-12-18 | 2008-07-15 | Collagen Corporation | Crosslinked polymer compositions and methods for their use |
| US5866165A (en) | 1997-01-15 | 1999-02-02 | Orquest, Inc. | Collagen-polysaccharide matrix for bone and cartilage repair |
| EP0887070B1 (en) | 1997-05-30 | 2004-12-22 | Kibun Food ChemiFA Co., Ltd. | External composition for skin comprising sphingoglycolipid |
| FR2769499B1 (fr) | 1997-10-10 | 2000-01-14 | Oreal | Procede de deformation permanente des matieres keratiniques sans rincage intermediaire |
| US6110487A (en) | 1997-11-26 | 2000-08-29 | Keraplast Technologies Ltd. | Method of making porous keratin scaffolds and products of same |
| US5932552A (en) * | 1997-11-26 | 1999-08-03 | Keraplast Technologies Ltd. | Keratin-based hydrogel for biomedical applications and method of production |
| JP3360810B2 (ja) | 1998-04-14 | 2003-01-07 | ペンタックス株式会社 | 骨補填材の製造方法 |
| US6572845B2 (en) | 1998-10-16 | 2003-06-03 | Burt D. Ensley | Recombinant hair treatment compositions |
| WO2000041739A1 (en) * | 1999-01-15 | 2000-07-20 | University Of Utah Research Foundation | Attachment of acid moiety-containing biomolecules to activated polymeric surfaces |
| US6696073B2 (en) * | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
| US6294187B1 (en) * | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
| AU6406700A (en) * | 1999-03-16 | 2000-10-04 | Regeneration Technologies, Inc. | Molded implants for orthopedic applications |
| JP2002543840A (ja) | 1999-05-19 | 2002-12-24 | インサイト・ゲノミックス・インコーポレイテッド | 細胞外シグナル伝達分子 |
| US6762158B2 (en) | 1999-07-01 | 2004-07-13 | Johnson & Johnson Consumer Companies, Inc. | Personal care compositions comprising liquid ester mixtures |
| ES2157807B1 (es) | 1999-07-09 | 2002-03-16 | Consejo Superior Investigacion | Composiciones y uso extracto de lipidos internos de la lana en la preparacion de productos para el tratamiento y cuidado de la piel. |
| US6544548B1 (en) | 1999-09-13 | 2003-04-08 | Keraplast Technologies, Ltd. | Keratin-based powders and hydrogel for pharmaceutical applications |
| US6783546B2 (en) | 1999-09-13 | 2004-08-31 | Keraplast Technologies, Ltd. | Implantable prosthetic or tissue expanding device |
| US20020004068A1 (en) | 2000-01-28 | 2002-01-10 | Isotta Di Drusco | Composition |
| DE10036749A1 (de) | 2000-07-28 | 2002-02-07 | Schwarzkopf Gmbh Hans | Dauerwellverfahren |
| US20020183858A1 (en) | 2001-06-05 | 2002-12-05 | Contiliano Joseph H. | Attachment of absorbable tissue scaffolds to scaffold fixation devices |
| MXPA04000351A (es) | 2001-07-13 | 2005-03-07 | Stichting I Voor Zuivelonde | Productos basados en queratina y metodos para su produccion. |
| ATE373678T1 (de) | 2001-07-17 | 2007-10-15 | Keratec Ltd | Herstellung löslicher keratinderivate |
| CN1158416C (zh) | 2001-08-30 | 2004-07-21 | 陈福库 | 角蛋白复合纤维及其制造方法 |
| CN100560639C (zh) | 2001-08-31 | 2009-11-18 | 凯瑞泰克有限公司 | 由s-磺化角蛋白蛋白质制备的泡沫材料、其制备方法及粘合剂材料 |
| CN1425813A (zh) | 2001-12-12 | 2003-06-25 | 中国科学院化学研究所 | 含动物蛋白质的合成纤维及其制备方法 |
| US6846940B2 (en) | 2002-01-22 | 2005-01-25 | L'oreal | Ceramides, compositions thereof and methods of use thereof |
| WO2004047774A1 (en) | 2002-11-28 | 2004-06-10 | Keratec Limited | Personal care formulations containing keratin |
| US7671012B2 (en) | 2004-02-10 | 2010-03-02 | Biosurface Engineering Technologies, Inc. | Formulations and methods for delivery of growth factor analogs |
-
2003
- 2003-06-10 NZ NZ550755A patent/NZ550755A/en not_active IP Right Cessation
- 2003-06-10 JP JP2004510856A patent/JP4551761B2/ja not_active Expired - Lifetime
- 2003-06-10 CN CNB038193280A patent/CN100506294C/zh not_active Expired - Lifetime
- 2003-06-10 BR BR0311723-5A patent/BR0311723A/pt not_active Application Discontinuation
- 2003-06-10 US US10/517,378 patent/US7297342B2/en not_active Expired - Lifetime
- 2003-06-10 EP EP03733659A patent/EP1534353A4/en not_active Withdrawn
- 2003-06-10 CA CA002488721A patent/CA2488721A1/en not_active Abandoned
- 2003-06-10 MX MXPA04012434A patent/MXPA04012434A/es active IP Right Grant
- 2003-06-10 WO PCT/NZ2003/000116 patent/WO2003103737A1/en not_active Ceased
- 2003-06-10 AU AU2003238745A patent/AU2003238745B2/en not_active Ceased
-
2004
- 2004-12-02 ZA ZA200409777A patent/ZA200409777B/en unknown
-
2007
- 2007-10-09 US US11/907,021 patent/US7892572B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20080039951A1 (en) | 2008-02-14 |
| MXPA04012434A (es) | 2005-10-19 |
| WO2003103737A1 (en) | 2003-12-18 |
| JP4551761B2 (ja) | 2010-09-29 |
| US7892572B2 (en) | 2011-02-22 |
| CA2488721A1 (en) | 2003-12-18 |
| US7297342B2 (en) | 2007-11-20 |
| CN1674946A (zh) | 2005-09-28 |
| AU2003238745B2 (en) | 2008-12-11 |
| CN100506294C (zh) | 2009-07-01 |
| NZ550755A (en) | 2009-06-26 |
| EP1534353A1 (en) | 2005-06-01 |
| AU2003238745A1 (en) | 2003-12-22 |
| EP1534353A4 (en) | 2010-10-13 |
| JP2005536242A (ja) | 2005-12-02 |
| US20050232963A1 (en) | 2005-10-20 |
| BR0311723A (pt) | 2005-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7892572B2 (en) | Orthopaedic materials derived from keratin | |
| CA2213533C (en) | Resorbable extracellular matrix for reconstruction of cartilage tissue | |
| Balaji et al. | Characterization of keratin–collagen 3D scaffold for biomedical applications | |
| EP0562864B1 (en) | Heteromorphic sponges containing active agents | |
| WO2004041320A1 (ja) | 自己組織化したアパタイト／コラーゲン複合体を含むアパタイト／コラーゲン架橋多孔体及びその製造方法 | |
| JP2004528908A (ja) | 強化母材 | |
| CA2673337A1 (en) | Bone growth particles and osteoinductive composition thereof | |
| JPH11513590A (ja) | 骨移植マトリックス | |
| JPH03504736A (ja) | 移植用骨コラーゲンマトリックス | |
| BR112015013755B1 (pt) | Adesivo tecidual no qual o colágeno e a fibrina estão misturados e método para preparar o adesivo | |
| JPWO2006046414A1 (ja) | アパタイト／コラーゲン複合体繊維を含む多孔体の製造方法 | |
| WO2000029484A1 (en) | Process for preparing high density mechanically resistant insoluble collagen material in pure and combined forms | |
| US9737590B2 (en) | Self-assembly of collagen fibers from dermis, fascia and tendon for tissue augmentation and coverage of wounds and burns | |
| Zain et al. | Properties of tilapia collagen as a biomaterial for tissue engineering: a review | |
| US20080262632A1 (en) | Method for Producing Biomaterials From Bone Tissue and Material Used for Osteoplasty and Tissue Engineering | |
| RU2342162C1 (ru) | Способ получения биоматериалов из костной ткани и полученный этим способом материал для остеопластики и тканевой инженерии | |
| JP2005213449A (ja) | ゼラチンスポンジ | |
| Arslan et al. | Sophisticated biocomposite scaffolds from renewable biomaterials for bone tissue engineering | |
| O’Brien | The development of novel scaffolds for tissue engineering with a range of structural and mechanical properties | |
| Haarer et al. | Proteins and amino acid-derived polymers | |
| KR20050023298A (ko) | 케라틴 유래의 정형외과 재료 | |
| ES3041646T3 (en) | Collagen hydrogels useful as cell carriers | |
| AU2012204139B2 (en) | Bone growth particles and osteoinductive composition thereof | |
| US8685092B2 (en) | Material for osteoplasty and tissue engineering | |
| Rahman | Gelatin: Tissue Engineering |